Global H1N1 (swine flu) Vaccination Market Size study, By Treatment Type (Influenza, Meningococcal, Cervical Cancer, Pneumococcal, Hepatitis, Measles, Mumps, Rubella), By Route of Administration (Hospitals, Clinics, Research and Diagnostic Laboratories, Others), By End User (Hospitals, Clinics, Research and Diagnostic Laboratories, Others), and Regional Forecasts 2022-2028
- BIZ4950425
- 200 Pages
- March 2022
- Pharmaceuticals
The H1N1 virus is a term used for an infectious disease that is exhibits symptoms such as red-watery eyes, high fever, body aches, persistent cough, and headache. The infection is known to have a negative impact on the prevailing chronic illnesses, like Chronic Obstructive Pulmonary Disease (COPD), pneumonia, and bronchitis, and can be deadly in several cases. H1N1 vaccines are introduced as a preventive measure that is administered by the means of intranasal and intradermal procedures to present active immunization against the virus. The rising number of government subsidies for vaccine manufacturing, growing prevalence of epidemic H1N1 infection, increasing public-private partnerships for the supply of H1N1 vaccines are the major factors that may surge the market demand around the world. Additionally, a rising number of research and development activities, as well as increasing levels of respiratory diseases and immune-deficient disorders are further stimulating the market growth globally. For instance, in February 2020, Abbott India announced the introduction of an inactive vaccine in India against four strains of the influenza virus. Thereby, an increasing number of product launches propels the market demand. However, high costs & lengthy manufacturing processes impede the growth of the market over the forecast period of 2022-2028. Also, the shift from egg-based to cell-based manufacturing is anticipated to act as a catalyzing factor for the market demand during the forecast period.
The key regions considered for the global H1N1 (swine flu) Vaccination market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the growing expenditure of healthcare facilities, coupled with the increasing number of research and development activities.
Whereas, Asia-Pacific is anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as the rising number of infected populations, as well as growing awareness regarding the availability of the H1N1 vaccines, would create lucrative growth prospects for the H1N1 (swine flu) Vaccination market across the Asia-Pacific region.
Major market players included in this report are:
AstraZeneca
Novavax, Inc.
Zydus Cadila.
Panacea Biotec Ltd.
Sinovac Biotech Ltd.
Johnson & Johnson Services, Inc.
Green Cross Corp.
Abbott, Pfizer Inc.
Mitsubishi Tanabe Pharma Corporation.
Cipla Inc.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Treatment Type
Influenza
Meningococcal
Cervical Cancer
Pneumococcal
Hepatitis
Measles
Mumps
Rubella
By Route of Administration
Hospitals
Clinics
Research and Diagnostic Laboratories
Others
By End User
Intranasal
Conjugate
Attenuated Vaccines
Inactivated Vaccines
Intramuscular Vaccines
Toxoid
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028
Target Audience of the Global H1N1 (swine flu) Vaccination Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
1.2.1. Global H1N1 (swine flu) Vaccination Market, by Region, 2020-2028 (USD Billion)
1.2.2. Global H1N1 (swine flu) Vaccination Market, by Treatment Type, 2020-2028 (USD Billion)
1.2.3. Global H1N1 (swine flu) Vaccination Market, by Route of Administration, 2020-2028 (USD Billion)
1.2.4. Global H1N1 (swine flu) Vaccination Market, by End User, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global H1N1 (swine flu) Vaccination Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global H1N1 (swine flu) Vaccination Market Dynamics
3.1. H1N1 (swine flu) Vaccination Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Public-private partnerships for supply of H1N1 vaccine
3.1.1.2. Government subsidies for vaccine manufacture
3.1.2. Market Challenges
3.1.2.1. High costs & lengthy manufacturing process
3.1.3. Market Opportunities
3.1.3.1. Shift from egg-based to cell-based manufacturing
Chapter 4. Global H1N1 (swine flu) Vaccination Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2019-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global H1N1 (swine flu) Vaccination Market, by Treatment Type
6.1. Market Snapshot
6.2. Global H1N1 (swine flu) Vaccination Market by Treatment Type, Performance - Potential Analysis
6.3. Global H1N1 (swine flu) Vaccination Market Estimates & Forecasts by Treatment Type 2019-2028 (USD Billion)
6.4. H1N1 (swine flu) Vaccination Market, Sub Segment Analysis
6.4.1. Influenza
6.4.2. Meningococcal
6.4.3. Cervical Cancer
6.4.4. Pneumococcal
6.4.5. Hepatitis
6.4.6. Measles
6.4.7. Mumps
6.4.8. Rubella
Chapter 7. Global H1N1 (swine flu) Vaccination Market, by Route of Administration
7.1. Market Snapshot
7.2. Global H1N1 (swine flu) Vaccination Market by Route of Administration, Performance - Potential Analysis
7.3. Global H1N1 (swine flu) Vaccination Market Estimates & Forecasts by Route of Administration 2019-2028 (USD Billion)
7.4. H1N1 (swine flu) Vaccination Market, Sub Segment Analysis
7.4.1. Hospitals
7.4.2. Clinics
7.4.3. Research and Diagnostic Laboratories
7.4.4. Others
Chapter 8. Global H1N1 (swine flu) Vaccination Market, by End User
8.1. Market Snapshot
8.2. Global H1N1 (swine flu) Vaccination Market by End User, Performance - Potential Analysis
8.3. Global H1N1 (swine flu) Vaccination Market Estimates & Forecasts by End User 2019-2028 (USD Billion)
8.4. H1N1 (swine flu) Vaccination Market, Sub Segment Analysis
8.4.1. Intranasal
8.4.2. Conjugate
8.4.3. Attenuated Vaccines
8.4.4. Inactivated Vaccines
8.4.5. Intramuscular Vaccines
8.4.6. Toxoid
Chapter 9. Global H1N1 (swine flu) Vaccination Market, Regional Analysis
9.1. H1N1 (swine flu) Vaccination Market, Regional Market Snapshot
9.2. North America H1N1 (swine flu) Vaccination Market
9.2.1. U.S. H1N1 (swine flu) Vaccination Market
9.2.1.1. Treatment Type estimates & forecasts, 2019-2028
9.2.1.2. Route of Administration estimates & forecasts, 2019-2028
9.2.1.3. End User estimates & forecasts, 2019-2028
9.2.2. Canada H1N1 (swine flu) Vaccination Market
9.3. Europe H1N1 (swine flu) Vaccination Market Snapshot
9.3.1. U.K. H1N1 (swine flu) Vaccination Market
9.3.2. Germany H1N1 (swine flu) Vaccination Market
9.3.3. France H1N1 (swine flu) Vaccination Market
9.3.4. Spain H1N1 (swine flu) Vaccination Market
9.3.5. Italy H1N1 (swine flu) Vaccination Market
9.3.6. Rest of Europe H1N1 (swine flu) Vaccination Market
9.4. Asia-Pacific H1N1 (swine flu) Vaccination Market Snapshot
9.4.1. China H1N1 (swine flu) Vaccination Market
9.4.2. India H1N1 (swine flu) Vaccination Market
9.4.3. Japan H1N1 (swine flu) Vaccination Market
9.4.4. Australia H1N1 (swine flu) Vaccination Market
9.4.5. South Korea H1N1 (swine flu) Vaccination Market
9.4.6. Rest of Asia Pacific H1N1 (swine flu) Vaccination Market
9.5. Latin America H1N1 (swine flu) Vaccination Market Snapshot
9.5.1. Brazil H1N1 (swine flu) Vaccination Market
9.5.2. Mexico H1N1 (swine flu) Vaccination Market
9.6. Rest of The World H1N1 (swine flu) Vaccination Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. AstraZeneca
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Novavax, Inc.
10.2.3. Zydus Cadila.
10.2.4. Panacea Biotec Ltd.
10.2.5. Sinovac Biotech Ltd.
10.2.6. Johnson & Johnson Services, Inc.
10.2.7. Green Cross Corp.
10.2.8. Abbott, Pfizer Inc.
10.2.9. Mitsubishi Tanabe Pharma Corporation.
10.2.10. Cipla Inc.
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
TABLE 1. Global H1N1 (swine flu) Vaccination Market, report scope
TABLE 2. Global H1N1 (swine flu) Vaccination Market estimates & forecasts by Region 2019-2028 (USD Billion)
TABLE 3. Global H1N1 (swine flu) Vaccination Market estimates & forecasts by Treatment Type 2019-2028 (USD Billion)
TABLE 4. Global H1N1 (swine flu) Vaccination Market estimates & forecasts by Route of Administration 2019-2028 (USD Billion)
TABLE 5. Global H1N1 (swine flu) Vaccination Market estimates & forecasts by End User 2019-2028 (USD Billion)
TABLE 6. Global H1N1 (swine flu) Vaccination Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 7. Global H1N1 (swine flu) Vaccination Market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 8. Global H1N1 (swine flu) Vaccination Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 9. Global H1N1 (swine flu) Vaccination Market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 10. Global H1N1 (swine flu) Vaccination Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 11. Global H1N1 (swine flu) Vaccination Market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 12. Global H1N1 (swine flu) Vaccination Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 13. Global H1N1 (swine flu) Vaccination Market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 14. Global H1N1 (swine flu) Vaccination Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 15. Global H1N1 (swine flu) Vaccination Market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 16. U.S. H1N1 (swine flu) Vaccination Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 17. U.S. H1N1 (swine flu) Vaccination Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 18. U.S. H1N1 (swine flu) Vaccination Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 19. Canada H1N1 (swine flu) Vaccination Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 20. Canada H1N1 (swine flu) Vaccination Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 21. Canada H1N1 (swine flu) Vaccination Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 22. UK H1N1 (swine flu) Vaccination Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 23. UK H1N1 (swine flu) Vaccination Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 24. UK H1N1 (swine flu) Vaccination Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 25. Germany H1N1 (swine flu) Vaccination Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 26. Germany H1N1 (swine flu) Vaccination Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 27. Germany H1N1 (swine flu) Vaccination Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 28. RoE H1N1 (swine flu) Vaccination Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 29. RoE H1N1 (swine flu) Vaccination Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 30. RoE H1N1 (swine flu) Vaccination Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 31. China H1N1 (swine flu) Vaccination Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 32. China H1N1 (swine flu) Vaccination Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 33. China H1N1 (swine flu) Vaccination Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 34. India H1N1 (swine flu) Vaccination Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 35. India H1N1 (swine flu) Vaccination Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 36. India H1N1 (swine flu) Vaccination Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 37. Japan H1N1 (swine flu) Vaccination Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 38. Japan H1N1 (swine flu) Vaccination Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 39. Japan H1N1 (swine flu) Vaccination Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 40. RoAPAC H1N1 (swine flu) Vaccination Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 41. RoAPAC H1N1 (swine flu) Vaccination Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 42. RoAPAC H1N1 (swine flu) Vaccination Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 43. Brazil H1N1 (swine flu) Vaccination Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 44. Brazil H1N1 (swine flu) Vaccination Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 45. Brazil H1N1 (swine flu) Vaccination Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 46. Mexico H1N1 (swine flu) Vaccination Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 47. Mexico H1N1 (swine flu) Vaccination Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 48. Mexico H1N1 (swine flu) Vaccination Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 49. RoLA H1N1 (swine flu) Vaccination Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 50. RoLA H1N1 (swine flu) Vaccination Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 51. RoLA H1N1 (swine flu) Vaccination Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 52. Row H1N1 (swine flu) Vaccination Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 53. Row H1N1 (swine flu) Vaccination Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 54. Row H1N1 (swine flu) Vaccination Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 55. List of secondary sources, used in the study of global H1N1 (swine flu) Vaccination Market
TABLE 56. List of primary sources, used in the study of global H1N1 (swine flu) Vaccination Market
TABLE 57. Years considered for the study
TABLE 58. Exchange rates considered
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
